428438-46-4Relevant academic research and scientific papers
Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates
-
, (2008/06/13)
Pharmaceutical preparation comprising at least one phosphodiesterase V inhibitor and at least one nitrate for the preparation of a medicament for the treatment of angina, high blood pressure, pulmonary hypertension, congestive heart failure (CHF), chronic
Pharmacuetical formulation comprising puyrazolo[4,-3-d]pyrimidines and antithrombotics, calcium antagonists, or prostaglandins or prostaglandin derivatives
-
, (2008/06/13)
The invention relates to a pharmaceutical preparation containing at least one compound of formula (I), wherein R1, R2, R3, R4 and X have the meanings as cited in claim No. 1, and to their physiologically safe salts and/or solvates, and containing; a) at l
Use of pyrazolo[4,3-d]pyrimidines
-
, (2008/06/13)
The invention relates to the use of pyrazolo[4,3-d]pyrimidines of formula (I), and the physiologically acceptable salts and/or solvates thereof, for producing a medicament for treating cancer.
